Evaluating Burkholderia pseudomallei Bip proteins as vaccines and Bip antibodies as detection agents

Area of Science:

• Microbiology
• Immunology
• Pathogen Research

Background:

• * Burkholderia pseudomallei is a significant biothreat pathogen causing melioidosis.
• * The type III secretion system (TTSS-3) is crucial for B. pseudomallei virulence.
• * TTSS components are potential targets for diagnostics and vaccines in other pathogens.

Purpose of the Study:

• * To investigate the potential of BipB, BipC, and BipD from B. pseudomallei's TTSS-3 as diagnostic agents and vaccine candidates.
• * To assess the conservation and immunogenicity of these TTSS-3 components.

Main Methods:

• * Sequence analysis of BipB, BipC, and BipD across B. pseudomallei and B. mallei isolates.
• * Generation and characterization of monoclonal antibodies (mAbs) against Bip proteins.
• * Expression analysis of Bip proteins in B. pseudomallei and B. mallei.
• * Vaccination of mice with individual Bip proteins to assess protection against melioidosis.
• * ELISA to detect antibodies to Bip proteins in human melioidosis patients.

Main Results:

• * BipB, BipC, and BipD sequences are highly conserved in B. pseudomallei and B. mallei.
• * Monoclonal antibodies recognized both native and denatured Bip proteins.
• * B. pseudomallei and B. mallei did not express detectable BipB or BipD under tested conditions.
• * Vaccination with single Bip proteins did not confer protection against experimental melioidosis.
• * Human melioidosis patients showed antibodies to BipB and BipD, but diagnostic accuracy was low.

Conclusions:

• * BipB, BipC, and BipD are conserved TTSS-3 components in Burkholderia species.
• * These proteins hold potential for diagnostic applications, though with limitations in accuracy.
• * BipB, BipC, and BipD are not effective as standalone protective antigens for melioidosis vaccines.